title: The successful use of plasma exchange and immunosuppression in the management of acquired Glanzmann's thrombasthenia.
authors.forename: R V
authors.initials: RV
authors.lastname: Thomas
authors.forename: H
authors.initials: H
authors.lastname: Bessos
authors.forename: M L
authors.initials: ML
authors.lastname: Turner
authors.forename: E H
authors.initials: EH
authors.lastname: Horn
authors.forename: C A
authors.initials: CA
authors.lastname: Ludlam
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects; D001379:Azathioprine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy / Q000209:etiology; D006493:Heparin / Q000009:adverse effects; D024764:Hirudin Therapy / Q000379:methods; D006801:Humans; D007084:Iliac Vein; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008875:Middle Aged; D010951:Plasma Exchange / Q000379:methods*; D013915:Thrombasthenia / Q000628:therapy*; D013921:Thrombocytopenia / Q000139:chemically induced; D020246:Venous Thrombosis / Q000139:chemically induced / Q000188:drug therapy
chemical_list: D000925:Anticoagulants; D007166:Immunosuppressive Agents; D006493:Heparin; D001379:Azathioprine